Research Keyword: ELISA

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice

mycolabadmin

This study tested whether psilocybin (an active compound from magic mushrooms) combined with eugenol (a natural compound from cloves) could reduce brain inflammation in mice. Researchers gave mice a substance that triggers inflammation in the brain and then treated them with these compounds before or after the inflammation started. The combination treatment, especially at a 1:50 ratio of psilocybin to eugenol, significantly reduced multiple inflammatory markers in the brain, suggesting this combination could potentially be helpful for treating brain inflammation-related conditions.

Read More »

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

This study compared two blood tests for diagnosing chronic pulmonary aspergillosis (CPA), a chronic fungal lung infection caused by Aspergillus. The rapid immunochromatographic test (ICT) performed better overall than the traditional ELISA laboratory test, making it more useful as a quick diagnostic tool, especially in areas without advanced laboratory facilities. However, both tests were less accurate in patients who had recently taken antifungal or steroid medications.

Read More »

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

This research developed a special antibody test to quickly identify deadly flesh-eating fungi called Apophysomyces and Saksenaea, which cause serious skin and soft tissue infections. These fungi are difficult to identify because they don’t form spores on standard laboratory media. The new test uses a simple method combining antibody detection with a rapid lateral-flow test, similar to a COVID-19 test, making diagnosis faster and more reliable in hospitals that don’t have access to expensive equipment.

Read More »

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

Chronic pulmonary aspergillosis is a serious fungal lung infection that often develops after tuberculosis. This study compared two blood tests for diagnosing this disease: a quick point-of-care test and a traditional lab test. The quick test performed better overall and could be used in areas without advanced laboratory equipment, though previous antifungal or steroid medications can reduce its effectiveness.

Read More »

Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis

mycolabadmin

Researchers developed a new test to detect Aspergillus fungal infections using an antibody that recognizes a fungal component called GAG. The test worked very well in mouse studies, reliably detecting the fungus in blood and other body fluids. However, when tested with samples from infected patients, the test could not find GAG in the blood or other fluids, though it could see the fungus in lung tissue. This suggests either patients don’t produce enough GAG in their bloodstream, or something in human biology interferes with detection.

Read More »

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

Researchers developed a new diagnostic tool using specially designed antibodies to quickly identify dangerous flesh-eating fungi (Apophysomyces and Saksenaea) that cause severe infections. These fungi are particularly difficult to diagnose because they don’t produce spores on standard laboratory cultures. The new test can identify these pathogens in just 24-48 hours, much faster than traditional methods, which is critical since these infections progress rapidly and require immediate treatment. This advancement is especially important for hospitals in developing countries where expensive diagnostic equipment is unavailable.

Read More »

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

Chronic pulmonary aspergillosis (CPA) is a serious fungal lung infection that primarily affects people with existing lung conditions. This study compared two methods to detect the disease: a fast, portable test (ICT) and a traditional laboratory test (ELISA). The faster ICT test was more accurate overall and can provide results quickly in areas without advanced laboratory facilities. However, patients already taking antifungal medications had lower test accuracy with both methods.

Read More »
Scroll to Top